Scientist, Nonclinical Safety
Gilead Sciences(3 months ago)
About this role
Gilead Sciences is hiring a Research Scientist within its Nonclinical Safety and Pathobiology group to support development of innovative medicines across therapeutic areas such as HIV, liver disease, cancer, and inflammation. The role is based at Gilead’s global headquarters in Foster City, California, within a fast-paced, data-driven research environment supporting drug development candidates from early research through registration and post-approval.
Required Skills
- Toxicology
- Nonclinical Safety
- Pathology
- Pharmacology
- Drug Metabolism
- Regulatory Writing
- Protocol Review
- Data Interpretation
- Study Reporting
- Project Management
+5 more
Qualifications
- PhD in Toxicology
- PhD in Pharmacology
- BS
- MS
- Board Certification (Desirable)
About Gilead Sciences
gilead.comGilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.
View more jobs at Gilead Sciences →Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at Gilead Sciences
Similar Jobs
Associate Director, Nonclinical Safety
Sarepta Therapeutics(3 months ago)
Principal Scientist, Toxicology
CSL Innovation(3 months ago)
Senior Director, Nonclinical Safety Evaluation
Moderna(17 days ago)
Principal Scientist, Regulatory Toxicology
CSL Innovation(1 month ago)
Principal Scientist - Toxicology
AbCellera(19 days ago)
Director of Toxicology
Scholar Rock(24 days ago)